Search Results for keywords:"FTZ Board authorization"

Found 2 results

Search Results: keywords:"FTZ Board authorization"

💰 Only
Oldest Newest
  • 2025-07027 — Foreign-Trade Zone (FTZ) 265; Authorization of Production Activity; Unimacts Company; (Steel Products); Conroe, Texas
    Type:Notice
    Citation:90 FR 17240
    Reading Time:less than a minute

    The Foreign-Trade Zones (FTZ) Board has authorized Unimacts Company in Conroe, Texas, to conduct production activity involving steel products within FTZ 265. This decision followed a submission by the City of Conroe and an invitation for public comments that was announced in the Federal Register on January 8, 2025. On April 18, 2025, the FTZ Board concluded that no further review was required, allowing Unimacts to proceed under the conditions set by the FTZ Act and the Board's regulations. The authorization aims to facilitate economic activity within the foreign-trade zone.

    Simple Explanation

    The Foreign-Trade Zones Board said that a company called Unimacts in Texas can make steel things in a special area where they get some tax benefits, like a special factory space. They decided this after checking rules and making sure everything was okay with no need for extra checks.

  • 2025-06930 — Foreign-Trade Zone (FTZ) 49; Authorization of Production Activity; Sanofi US Services Inc.; (Pharmaceutical Products); Ridgefield, New Jersey
    Type:Notice
    Citation:90 FR 17030
    Reading Time:less than a minute

    Sanofi US Services Inc. proposed new production activities at its facility in Ridgefield, New Jersey, and submitted a notification to the Foreign-Trade Zones (FTZ) Board on December 18, 2024. This notification was reviewed according to the Board's regulations, and a public comment invitation was published in the Federal Register on January 6, 2025. By April 17, 2025, the Board decided that no further review was needed, and authorized the activity under the FTZ Act and regulations. The decision was communicated to Sanofi with a formal notice from the Executive Secretary, Elizabeth Whiteman.

    Simple Explanation

    Sanofi, a medicine company, got permission to start making new medicines in New Jersey. Some people had the chance to say what they thought about this idea and nobody said it needed more checking, so it was approved quickly.